Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GeNeuro
Research
How GeNeuro's experimental MS drug might help treat COVID-19
GeNeuro is developing an antibody against human endogenous retrovirus W to treat MS, but the drug's target may also be relevant to COVID.
Angus Liu
Apr 15, 2021 1:30am
GeNeuro raises €17.5M for multiple sclerosis clinical trial
Jan 31, 2020 8:35am
Servier drops GeNeuro’s MS drug after midphase miss
Sep 18, 2018 4:28am
Bucking a negative trend, Servier-backed GeNeuro gets off its IPO
Apr 15, 2016 8:25am